New Data On Investigational Therapy For Thymidine Kinase 2 Deficiency Presented At Muscular Dystrophy Association (MDA) 2025 Conference
Clinical data highlight survival benefits and improvement in functional motor outcomes associated with treatment with doxecitine (dC) and ...
The Pharma Letter20h
UCB presents new data on thymidine kinase 2 deficiency treatment
Belgium’s largest drugmaker UCB (Euronext: UCB) today announced positive data from studies involving its investigational ...
PharmiWeb21h
New data on investigational therapy for thymidine…
UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...
Medscape15d
Nucleoside and Nucleotide Reverse Transcriptase Inhibitors in Children
2007;27(8):509-531. Antiretroviral drugs (ARVs) can be divided into four different classes according to their modes of action: nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs or ...
C&EN15d
E. B. Hershberg Award: Taming Inflammation by Tuning Purinergic Signaling
Each organ and tissue in the body expresses some combination of this family of cell-surface receptors, along with the enzymes and transporters that form, degrade, and process the native nucleoside and ...
Science Daily22d
New genetic risk score identifies individuals at risk for heart disease who may benefit most from cholesterol-lowering therapies
The research team identified 35 single nucleotide polymorphisms -- single "letter" genetic changes -- that were connected to EC function and CAD, to create a risk score that they then used to make ...
C&EN24d
Inhibitors of SAMHD1 Obtained from Chemical Tethering to the Guanine Antiviral Acyclovir
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, 725 North Wolfe Street, Baltimore, Maryland 21205, United States ...